1099 — Sinopharm Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$57.05bn
- HK$131.43bn
- CNY584.51bn
- 61
- 96
- 28
- 70
Annual cashflow statement for Sinopharm Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 15,598 | 17,003 | 18,564 | 19,512 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4,335 | 4,558 | 4,708 | 2,596 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12,375 | -16,175 | -6,473 | -9,365 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11,155 | 9,308 | 20,964 | 17,173 | — |
| Capital Expenditures | -2,087 | -2,256 | -2,418 | -2,336 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -115 | 989 | -1,172 | 1,391 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,203 | -1,267 | -3,590 | -945 | — |
| Financing Cash Flow Items | -6,146 | -5,997 | -6,274 | -5,471 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,026 | -14,693 | -5,693 | -7,644 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10,986 | -6,649 | 11,692 | 8,587 | — |